EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?

Detalles Bibliográficos
Autores principales: Sesboüé, R, Le Pessot, F, Di Fiore, F, Frebourg, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261662/
https://www.ncbi.nlm.nih.gov/pubmed/22187031
http://dx.doi.org/10.1038/bjc.2011.570
_version_ 1782221612694634496
author Sesboüé, R
Le Pessot, F
Di Fiore, F
Frebourg, T
author_facet Sesboüé, R
Le Pessot, F
Di Fiore, F
Frebourg, T
author_sort Sesboüé, R
collection PubMed
description
format Online
Article
Text
id pubmed-3261662
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-32616622013-01-17 EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain? Sesboüé, R Le Pessot, F Di Fiore, F Frebourg, T Br J Cancer Letter to the Editor Nature Publishing Group 2012-01-17 2011-12-20 /pmc/articles/PMC3261662/ /pubmed/22187031 http://dx.doi.org/10.1038/bjc.2011.570 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Sesboüé, R
Le Pessot, F
Di Fiore, F
Frebourg, T
EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
title EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
title_full EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
title_fullStr EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
title_full_unstemmed EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
title_short EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
title_sort egfr alterations and response to anti-egfr therapy: is it a matter of gene amplification or gene copy number gain?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261662/
https://www.ncbi.nlm.nih.gov/pubmed/22187031
http://dx.doi.org/10.1038/bjc.2011.570
work_keys_str_mv AT sesbouer egfralterationsandresponsetoantiegfrtherapyisitamatterofgeneamplificationorgenecopynumbergain
AT lepessotf egfralterationsandresponsetoantiegfrtherapyisitamatterofgeneamplificationorgenecopynumbergain
AT difioref egfralterationsandresponsetoantiegfrtherapyisitamatterofgeneamplificationorgenecopynumbergain
AT frebourgt egfralterationsandresponsetoantiegfrtherapyisitamatterofgeneamplificationorgenecopynumbergain

Ejemplares similares